Get the Stockscreener App
2.67
4.30%
-0.12
After Hours:
2.67
Maravai Lifesciences Holdings Inc stock is traded at $2.67, with a volume of 1.20M.
It is down -4.30% in the last 24 hours and down -0.74% over the past month.
Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
See More
Previous Close:
$2.79
Open:
$2.78
24h Volume:
1.20M
Relative Volume:
0.78
Market Cap:
$386.29M
Revenue:
$288.95M
Net Income/Loss:
$-119.03M
P/E Ratio:
-2.965
EPS:
-0.9005
Net Cash Flow:
$60.67M
1W Performance:
+6.37%
1M Performance:
-0.74%
6M Performance:
+2.30%
1Y Performance:
-68.99%
1-Day Range:
$2.64
$2.7945
1-Week Range:
$2.42
$2.80
52-Week Range:
$1.665
$9.50
Maravai Lifesciences Holdings Inc Stock (MRVI) Company Profile
Name
Maravai Lifesciences Holdings Inc
Sector
Industry
Phone
(858) 546-0004
Address
10770 WATERIDGE CIRCLE SUITE 200, SAN DIEGO
Compare MRVI with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MRVI
Maravai Lifesciences Holdings Inc
|
2.67 | 376.16M | 288.95M | -119.03M | 60.67M | -0.9005 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Maravai Lifesciences Holdings Inc Stock (MRVI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Dec-19-24 | Initiated | Guggenheim | Neutral |
| Dec-05-24 | Downgrade | Goldman | Neutral → Sell |
| Nov-14-24 | Initiated | Wolfe Research | Peer Perform |
| Nov-08-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-28-24 | Initiated | Wells Fargo | Overweight |
| Aug-13-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Apr-10-24 | Initiated | Craig Hallum | Buy |
| Dec-12-23 | Upgrade | BofA Securities | Neutral → Buy |
| Aug-08-23 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| May-23-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| May-09-23 | Downgrade | Goldman | Buy → Neutral |
| Jan-05-23 | Downgrade | UBS | Buy → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Nov-03-22 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Dec-16-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Dec-15-20 | Initiated | BofA Securities | Buy |
| Dec-15-20 | Initiated | Credit Suisse | Outperform |
| Dec-15-20 | Initiated | Goldman | Buy |
| Dec-15-20 | Initiated | Jefferies | Buy |
| Dec-15-20 | Initiated | Robert W. Baird | Outperform |
| Dec-15-20 | Initiated | Stifel | Buy |
| Dec-15-20 | Initiated | William Blair | Outperform |
| Dec-14-20 | Initiated | UBS | Buy |
View All
Maravai Lifesciences Holdings Inc Stock (MRVI) Latest News
Statistical indicators supporting Maravai LifeSciences Holdings Inc.’s strengthPortfolio Value Summary & Daily Stock Trend Watchlist - Newser
Can Maravai LifeSciences Holdings Inc. recover in the next quarter2025 Momentum Check & Expert Curated Trade Ideas - Newser
Will Maravai LifeSciences Holdings Inc. price bounce be sustainableJuly 2025 Technicals & Daily Stock Momentum Reports - Newser
Can trapped investors hope for a rebound in Maravai LifeSciences Holdings Inc.2025 Market Trends & Fast Entry Momentum Trade Alerts - Newser
Top chart patterns to watch in Maravai LifeSciences Holdings Inc.Weekly Trade Analysis & High Accuracy Investment Entry Signals - Newser
Combining machine learning predictions for Maravai LifeSciences Holdings Inc.M&A Rumor & Low Risk Entry Point Tips - Newser
Analyzing net buyer seller activity in Maravai LifeSciences Holdings Inc.Trade Risk Report & Daily Stock Trend Reports - Newser
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q2 2025 Earnings Call Transcript - MSN
Voleon Capital Management LP Invests $296,000 in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Maravai LifeSciences Holdings Inc. stock momentum explainedJuly 2025 Short Interest & Smart Money Movement Alerts - Newser
What the charts say about Maravai LifeSciences Holdings Inc. todayBear Alert & Momentum Based Trading Signals - Newser
Should you hold or exit Maravai LifeSciences Holdings Inc. now2025 Year in Review & Weekly Top Gainers Alerts - Newser
What machine learning models say about Maravai LifeSciences Holdings Inc.Gold Moves & Fast Entry Momentum Trade Alerts - Newser
Will breakout in Maravai LifeSciences Holdings Inc. lead to full recoveryWeekly Volume Report & Entry and Exit Point Strategies - Newser
PenderFund Capital Management Ltd. Raises Position in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Philosophy Capital Management LLC Purchases New Holdings in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Promising Penny Stocks To Consider In September 2025 - au.finance.yahoo.com
How to recover losses in Maravai LifeSciences Holdings Inc. stockJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - Newser
Will Maravai LifeSciences Holdings Inc. see short term momentumMarket Activity Report & Real-Time Volume Spike Alerts - Newser
Using fundamentals and technicals on Maravai LifeSciences Holdings Inc.2025 Trade Ideas & Weekly Top Performers Watchlists - Newser
Maravai LifeSciences Holdings, Inc. $MRVI Stake Increased by Parkman Healthcare Partners LLC - MarketBeat
Maravai LifeSciences Holdings Inc. stock trend outlook and recovery pathJuly 2025 Catalysts & Weekly High Momentum Picks - Newser
Price momentum metrics for Maravai LifeSciences Holdings Inc. explained2025 Performance Recap & Real-Time Volume Analysis - Newser
Order flow analysis tools used on Maravai LifeSciences Holdings Inc.July 2025 Reactions & Fast Exit/Entry Strategy Plans - Newser
Earnings visualization tools for Maravai LifeSciences Holdings Inc.Trade Exit Summary & Community Consensus Trade Signals - Newser
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Maravai LifeSciences Holdings, Inc. (MRVI) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
MARAVAI INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. - GlobeNewswire
How does Maravai LifeSciences Holdings Inc. correlate with NasdaqPortfolio Return Summary & Target Return Focused Stock Picks - Lancaster City Council
Nuveen LLC Makes New Investment in Maravai LifeSciences Holdings, Inc. $MRVI - MarketBeat
Is Maravai LifeSciences Holdings Inc. reversing from oversold territoryMarket Trend Summary & High Accuracy Swing Trade Signals - Newser
Momentum divergence signals in Maravai LifeSciences Holdings Inc. chartJuly 2025 Review & Expert Approved Momentum Ideas - Newser
Will a bounce in Maravai LifeSciences Holdings Inc. offer an exitJuly 2025 Fed Impact & High Yield Equity Trading Tips - Newser
Full technical analysis of Maravai LifeSciences Holdings Inc. stockWeekly Profit Recap & Daily Oversold Stock Bounce Ideas - Newser
Maravai LifeSciences Holdings Inc. stock trend forecastWeekly Gains Summary & Scalable Portfolio Growth Methods - Newser
Maravai Lifesciences Holdings Inc Stock (MRVI) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):